Watch this recent interview on Ticker Insight with Dr Steven Gourlay providing an update on Actinogen and our successful trial. Chronically elevated cortisol is associated with cognitive decline in Alzheimer’s Disease, and Xanamem has shown the ability to improve working memory and attention in healthy, older volunteers.
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
